financetom
Business
financetom
/
Business
/
American Vanguard CEO Eric G. Wintemute Steps Down; Timothy Donnelly to Serve as Acting CEO
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
American Vanguard CEO Eric G. Wintemute Steps Down; Timothy Donnelly to Serve as Acting CEO
Jul 15, 2024 6:43 AM

09:16 AM EDT, 07/15/2024 (MT Newswires) -- American Vanguard ( AVD ) said Monday that Eric G. Wintemute has stepped down as chief executive officer but will remain chairman of the board.

American Vanguard ( AVD ) said it has also established an Office of CEO, OCEO, which will include chief financial officer David Johnson, senior vice president of human resources Shirin Khosravi, chief information officer Timothy Donnelly, and board member Mark Bassett, the company said.

The company said Donnelly will serve as acting CEO until a successor is found.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
What's Going On With AMD Stock Wednesday?
What's Going On With AMD Stock Wednesday?
Feb 5, 2025
Advanced Micro Devices Inc ( AMD ) shares are falling Wednesday morning on the heels of the company’s fourth-quarter financial results. Multiple analysts also lowered price targets following the print. Q4 Revenue: $7.66 billion, versus estimates of $7.53 billion Q4 Adjusted EPS: $1.09, versus estimates of $1.08 Total revenue was up 12% year-over-year, led by Data Center revenue of $3.9 billion,...
EyePoint's Phase 2 Trial of Duravyu to Treat Diabetic Macular Edema Meets Endpoints; Shares Still Slump Pre-Bell
EyePoint's Phase 2 Trial of Duravyu to Treat Diabetic Macular Edema Meets Endpoints; Shares Still Slump Pre-Bell
Feb 5, 2025
09:12 AM EST, 02/05/2025 (MT Newswires) -- EyePoint Pharmaceuticals ( EYPT ) reported six-month results from a phase 2 trial of Duravyu to treat diabetic macular edema that met primary and secondary endpoints, but its shares still slumped in premarket trading. The company said the trial demonstrated clinically meaningful outcomes, such as continued safety with no Duravyu-related ocular or systemic...
Update: Ford Motor Appoints Sherry House as CFO
Update: Ford Motor Appoints Sherry House as CFO
Feb 5, 2025
09:12 AM EST, 02/05/2025 (MT Newswires) -- (Updates with additional leadership changes starting in the fifth paragraph.) Ford Motor ( F ) said Wednesday that Sherry House has been named to succeed John Lawler as chief financial officer, effective Feb. 6. House has served as vice president of finance since June 2024, the company said Lawler will continue to serve...
Walt Disney Fiscal First-Quarter Results Top Street Views; Disney+ Subscribers Decline Sequentially
Walt Disney Fiscal First-Quarter Results Top Street Views; Disney+ Subscribers Decline Sequentially
Feb 5, 2025
09:14 AM EST, 02/05/2025 (MT Newswires) -- Walt Disney's ( DIS ) fiscal first-quarter results topped market expectations amid entertainment business strengths, while the company recorded a sequential decline in Disney+ subscribers. The media and entertainment giant on Wednesday reported adjusted earnings of $1.76 a share for the quarter ended Dec. 28, up from $1.22 the year before and ahead...
Copyright 2023-2026 - www.financetom.com All Rights Reserved